What The Study Did: Researchers compared the accuracy of the blood biomarker tau phosphorylated at threonine 217 (P-tau217) with other biomarkers for distinguishing Alzheimer from other neurodegenerative diseases in individuals with or at risk for dementia.
Authors: Oskar Hansson, M.D., Ph.D., of Lund University in Lund, Sweden, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2020.12134)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.12134?guestAccessKey=42d098cb-7eca-4a1c-9d7b-9951b104b003&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072820
###
JAMA